Mammographic density - A useful biomarker for breast cancer risk in epidemiologic studies

Norsk Epidemiologi

Volumn 19, Issue 1, 2009, Pages 59-68

  Ursin, Giske ^a   Qureshi, Samera A ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; PLACEBO; RALOXIFENE; TAMOXIFEN; TIBOLONE;

ARTICLE; AUTOANALYSIS; AUTOMATION; BODY MASS; BREAST CANCER; CANCER RISK; CANCER SCREENING; COMPUTER ANALYSIS; DIGITAL MAMMOGRAPHY; DISEASE MARKER; GENETIC RISK; HORMONAL THERAPY; HUMAN; IMAGE DISPLAY; MAMMOGRAPHIC DENSITY; MEASUREMENT ERROR; PHYSICAL ACTIVITY; POSTMENOPAUSE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RADIOLOGICAL PARAMETERS; RADIOSENSITIVITY; VOLUMETRY;

EID: 68349093716     PISSN: 08032491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (99)

1. Saftlas AF, Szklo M. Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev, 9: 146-74, 1987.
2. Oza AM, Boyd NF. Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev, 15: 196-208, 1993.
3. Warner E, Lockwood G, Math M, Tritchler D, Boyd NF. The risk of breast cancer associated with mammographic parenchymal patterns: A meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev, 16: 67-72, 1992.
4. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 7: 1133-44, 1998.
5. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 15: 1159-69, 2006.
6. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst, 87: 670-5, 1995.
7. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst, 87: 1622-9, 1995.
8. Brisson J, Diorio C, Masse B. Wolfe's parenchymal pattern and percentage of the breast with mammographic densities: redundant or complementary classifications? Cancer Epidemiol Biomarkers Prev, 12: 728-32, 2003.
9. Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon C, Pike MC. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev, 12: 332-8, 2003.
10. Ziv E, Tice J, Smith-Bindman, R, Shepherd J, Cummings S, Kerlikowske K. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev, 13: 2090-5, 2004.
11. Torres-Mejia G, De Stavola B, Allen DS, Perez-Gavilan JJ, Ferreira JM, Fentiman IS, Dos Santos Silva I. Mammographic features and subsequent risk of breast cancer: a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies. Cancer Epidemiol Biomarkers Prev, 14: 1052-9, 2005.
12. Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN. Mammographic density and breast cancer risk: the multiethnic cohort study. Am J Epidemiol, 162: 743-52, 2005.
13. Tice JA, Cummings SR, Ziv E, Kerlikowske K. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat, 94: 115-22, 2005.
14. Carney PA, Miglioretti, DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, Geller BM, Abraham LA, Taplin SH, Dignan M, Cutter G, Ballard-Barbash R. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med, 138: 168-75, 2003.
15. Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey C, Key CR, Linver MN. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology, 209: 511-8, 1998.
16. Wang H, Bjurstam N, Bjorndal H, Braaten A, Eriksen L, Skaane P, Vitak B, Hofvind, S, Thoresen SO. Interval cancers in the Norwegian breast cancer screening program: frequency, characteristics and use of HRT. Int J Cancer, 94: 594-8, 2001.
17. Kavanagh AM, Byrnes GB, Nickson C, Cawson JN, Giles GG, Hopper JL, Gertig DM, English DR. Using mammographic density to improve breast cancer screening outcomes. Cancer Epidemiol Biomarkers Prev, 17: 2818-24, 2008.
18. Bright RA, Morrison AS, Brisson J, Burstein NA, Sadowsky NS, Kopans DB, Meyer JE. Relationship between mammographic and histologic features of breast tissue in women with benign biopsies. Cancer, 61: 266-71, 1988.
19. Urbanski S, Jensen HM, Cooke G, McFarlane D, Shannon P, Kruiko, V, Boyd NF. The association of histological and radiological indicators of breast cancer risk. Br J Cancer, 58: 474-9, 1988.
20. Wellings SR, Wolfe JN. Correlative studies of the histological and radiographic appearance of the breast parenchyma. Radiology, 129: 299-306, 1978.
21. Boyd NF, Jensen HM, Han HL. Relationship between mammographic and histological risk factors for breast cancer. J Natl Cancer Inst, 84: 1170-9, 1992.
22. Fisher ER, Palekar A, Kim WS, Redmond C. The histopathology of mammographic patterns. Am J Clin Pathol, 69: 421-6, 1978.
23. Moskowitz M, Gartside P, McLaughlin C. Mammographic patterns as markers for high-risk benign breast disease and incident cancers. Radiology, 134: 293-5, 1980.
24. Arthur JE, Ellis IO, Flowers C, Roebuck E, Elston CW, Blamey RW. The relationship of "high risk" mammographic patterns to histological risk factors for development of cancer in the human breast. Br J Radiol, 63: 845-9, 1990.
25. Hawes D, Downey S, Pearce CL, Bartow S, Wan P, Pike MC, Wu AH. Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity. Breast Cancer Res, 8: R24, 2006.
26. Khan QJ, Kimler BF, O'Dea AP, Zalles CM, Sharma P, Fabian CJ. Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer. Breast Cancer Res, 9: R35, 2007.
27. Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF. Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev, 10: 243-8, 2001.
28. Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH. Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res, 5: R129-35, 2003.
29. Barcellos-Hoff MH, Medina D. New highlights on stroma-epithelial interactions in breast cancer. Breast Cancer Res, 7: 33-6, 2005.
30. Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH. Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res, 7: R605-8, 2005.
31. Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, Hoppe JL. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med, 347: 886-94, 2002.
32. Stone J, Dite GS, Gunasekara A, English DR, McCredie MR, Giles GG, Cawson JN, Hegele RA, Chiarelli AM, Yaffe MJ, Boyd NF, Hopper JL. The heritability of mammographically dense and nondense breast tissue. Cancer Epidemiol Biomarkers Prev, 15: 612-7, 2006.
33. Ursin G, Lillie EO, Lee E, Cockburn M, Schork NJ, Cozen W, Parisky YR, Hamilton AS, Astrahan MA, Mack T. The relative importance of genetics and environment on mammographic density. Cancer Epidemiol Biomarkers Prev, 18: 102-12, 2009.
34. Kelemen LE, Sellers TA, Vachon CM. Can genes for mammographic density inform cancer aetiology? Nat Rev Cancer, 8: 812-23, 2008.
35. Lee E, Haiman CA, Ma H, Van Den Berg D, Bernstein L, Ursin G. The role of established breast cancer susceptibility loci in mammographic density in young women. Cancer Epidemiol Biomarkers Prev, 17: 258-60, 2008.
36. Tamimi RM, Cox D, Kraft P, Colditz GA, Hankinson SE, Hunter DJ. Breast cancer susceptibility loci and mammographic density. Breast Cancer Res, 10: R66, 2008.
37. Diorio C, Brisson J, Berube S, Pollak M. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels. Cancer Epidemiol Biomarkers Prev, 17: 880-8, 2008.
38. El-Bastawissi AY, White E, Mandelson MT, Taplin H. Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control, 11: 955-63, 2000.
39. Titus-Ernstoff L, Tosteson AN, Kasales C, Weiss J, Goodrich M, Hatch EE, Carney PA. Breast cancer risk factors in relation to breast density (United States). Cancer Causes Control, 17: 1281-90, 2006.
40. Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control, 11: 653-62, 2000.
41. Douglas JA, Roy-Gagnon MH, Zhou C, Mitchell BD, Shuldiner AR, Chan HP, Helvie MA. Mammographic breast density - evidence for genetic correlations with established breast cancer risk factors. Cancer Epidemiol Biomarkers Prev, 17: 3509-16, 2008.
42. Warren R. Hormones and mammographic breast density. Maturitasi, 49: 67-78, 2004.
43. Berkowitz JE, Gatewood OMB, Goldblum LE, Gayler BW. Hormonal replacement therapy: mammographic manifestations. Radiology, 174: 199-201, 1990.
44. Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology, 174: 487-90, 1990.
45. Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology, 196: 433-7, 1995.
46. Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Ann Intern Med, 130: 262-9, 1999.
47. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA, 285: 171-6, 2001.
48. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst, 95: 30-7, 2003.
49. McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS. Estrogen-plus-progestin use and mammographic density in postmenopausal women: women's health initiative randomized trial. J Natl Cancer Inst, 97: 1366-76, 2005.
50. Ursin G, Palla SL, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Greendale GA. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J Clin Oncol, 22: 2842-8, 2004.
51. Crandall CJ, Guan M, Laughlin GA, Ursin GA, Stanczyk FZ, Ingles SA, Barrett-Connor E, Greendale GA. Increases in serum estrone sulfate level are associated with increased mammographic density during menopausal hormone therapy. Cancer Epidemiol Biomarkers Prev, 17: 1674-81, 2008.
52. Lundstrom E, Wilczek B, von Palffy Z, Soderqvist G, von Schoultz B. Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol, 181: 348-52, 1999.
53. Persson I, Thurfjell E, Holmberg L. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol, 15: 3201-7, 1997.
54. Christodoulakos GE, Lambrinoudaki IV, Panoulis KP, Vourtsi AD, Vlachos L, Georgiou E, Creatsas GC. The effect of various regimens of hormone replacement therapy on mammographic breast density. Maturitas, 45: 109-18, 2003.
55. Christodoulakos GE, Lambrinoudaki IV, Vourtsi AD, Vlachou S, Creatsa M, Panoulis KP, Botsis D. The effect of low dose hormone therapy on mammographic breast density. Maturitas, 54: 78-85, 2006.
56. Bremnes Y, Ursin G, Bjurstam N, Lund E, Gram IT. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women. Int J Cancer, 120: 880-4, 2007.
57. Stuedal A, Ma H, Bjorndal H, Ursin G. Postmenopausal hormone use and mammographic density - a cross-sectional study among Norwegian women. Climacteric (in press), 2009.
58. Bruce D, Robinson J, McWilliams S, Reddy M, Fentiman I, Rymer J. Long-term effects of tibolone on mammographic density. Fertil Steril, 82: 1343-7, 2004.
59. Hofling M, Carlstrom K, Svane G, Azavedo E, Kloosterboer H, Von Schoultz B. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels - an association with mammographic density. Gynecol Endocrinol, 20: 110-5, 2005.
60. Brisson J, Brisson B, Cote G, Maunsell E, Berube S, Robert J. Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prevent, 9: 911-5, 2000.
61. Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst, 96: 621-8, 2004.
62. Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, Pike MC. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst, 86: 431-6, 1994.
63. Ursin G, Astrahan MA, Salane M, Parisky YR, Pearce JG, Daniels JR, Pike MC, Spicer DV. The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prevent, 7: 43-7, 1998.
64. Barrett-Connor E, Mosca L, Collins P, Geiger MJ, Grady D, Kornitzer M, McNabb MA, Wenger NK. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med, 355: 125-37, 2006.
65. Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA, 281: 2189-97, 1999.
66. Cirpan T, Akercan F, Itil IM, Gundem G, Bilgen I, Yucebilgin MS. Does raloxifene therapy affect mammographic breast cancer screening in postmenopausal patients? Eur J Gynaecol Oncol, 27: 177-8, 2006.
67. Eilertsen AL, Karssemeijer N, Skaane, Qvigstad E, Sandset PM. Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method. BJOG, 115: 773-9, 2008.
68. van Gils CH, Hendriks JH, Holland R, Karssemeijer N, Otten JD, Straatman H, Verbeek AL. Changes in mammographic breast density and concomitant changes in breast cancer risk. Eur J Cancer Prevent, 8: 509-15, 1999.
69. Wolfe J. Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol, 126: 1130-9, 1976.
70. Wolfe J. Breast parenchymal patterns and their changes with age. Radiology, 121: 545-52, 1976.
71. Breast Imaging Reporting and Data System (BI-RADS). Reston, VA: American College of Radiology, 2003.
72. Gram IT, Funkhouser E, Tabar L. The Tabar classification of mammographic parenchymal patterns. Eur J Radiol, 24: 131-6, 1997.
73. Gram IT, Bremnes Y, Ursin G, Maskarinec G, Bjurstam N, Lund E. Percentage density, Wolfe's and Tabar's mammographic patterns: agreement and association with risk factors for breast cancer. Breast Cancer Res, 7: R854-61, 2005.
74. Martin KE, Helvie MA, Zhou C, Roubidoux MA, Bailey JE, Paramagul C, Blane CE, Klein KA, Sonnad SS, Chan HP. Mammographic density measured with quantitative computer-aided method: comparison with radiologists' estimates and BI-RADS categories. Radiology, 240: 656-65, 2006.
75. Boyd NF, Byng J, Jong R, Fishell E, Little L, Miller AB, Lockwood G, Tritchle, D, Yaffe M. Quantitative classification of mammographic densities and breast cancer risks: Results from the Canadian National Breast Screening Study. J Natl Cancer Inst, 87: 670-5, 1995.
76. Byng JW, Boydt NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol, 39: 1629-38, 1994.
77. Yaffe MJ, Boyd NF, Byng JW, Jong RA, Fishell E, Lockwood GA, Little LE, Tritchler DL. Breast cancer risk and measured mammographic density. Eur J Cancer Prevent, 7: S47-S55, 1998.
78. Castella C, Kinkel K, Eckstein MP, Sottas PE, Verdun FR, Bochud FO. Semiautomatic mammographic parenchymal patterns classification using multiple statistical features. Acad Radiol, 14: 1486-99, 2007.
79. Chang RF, Chang-Chien KC, Takada E, Suri JS, Moon WK, Wu JH, Cho N, Wang YF, Chen DR. Three comparative approaches for breast density estimation in digital and screen film mammograms. Conf Proc IEEE Eng Med Biol Soc, 1: 4853-6, 2006.
80. Marias K, Linguraru MG, Gonzalez Ballester MA, Petroudi S, Tsiknakis M, Brady, SM. Automatic labelling and BIRADS characterisation of mammogram densities. Conf Proc IEEE Eng Med Biol Soc, 6: 6394-8, 2005.
81. Tagliafico A, Tagliafico G, Tosto S, Chiesa F, Martinoli C, Derchi LE, Calabrese M. Mammographic density estimation: Comparison among BI-RADS categories, a semi-automated software and a fully automated one. Breast, 18: 35-40, 2009.
82. Chang YH, Wang XH, Hardesty LA, Chang TS, Poller WR, Good WF, Gur D. Computerized assessment of tissue composition on digitized mammograms. Acad Radiol, 9: 899-905, 2002.
83. Huo Z, Giger ML, Wolverton DE, Zhong W, Cumming S, Olopade OI. Computerized analysis of mammographic parenchymal patterns for breast cancer risk assessment: feature selection. Med Phys, 27: 4-12, 2000.
84. Karssemeijer N. Automated classification of parenchymal patterns in mammograms. Phys Med Biol, 43: 365-78, 1998.
85. Li H, Giger ML, Olopade OI, Lan L. Fractal analysis of mammographic parenchymal patterns in breast cancer risk assessment. Acad Radiol, 14: 513-21, 2007.
86. Zhou C, Chan HP, Petrick N, Helvie MA, Goodsitt MM, Sahiner B, Hadjiiski LM. Computerized image analysis: estimation of breast density on mammograms. Med Phys, 28: 1056-69, 2001.
87. Glide-Hurst, CK, Duric N, Littrup P. Volumetric breast density evaluation from ultrasound tomography images. Med Phys, 35: 3988-97, 2008.
88. Khazen M, Warren RM, Boggis CR, Bryant EC, Reed S, Warsi I, Pointon LJ, Kwan-Lim GE, Thompson D, Eeles R, Easton D, Evans DG, Leach MO. A pilot study of compositional analysis of the breast and estimation of breast mammographic density using three-dimensional T1-weighted magnetic resonance imaging. Cancer Epidemiol Biomarkers Prev, 17: 2268-74, 2008.
89. Pawluczyk O, Augustine BJ, Yaffe MJ, Rico D, Yang J, Mawdsley GE, Boyd NF. A volumetric method for estimation of breast density on digitized screen-film mammograms. Med Phys, 30: 352-64, 2003.
90. Marias K, Behrenbruch C, Highnam R, Parbhoo S, Seifalian A, Brady MA. mammographic image analysis method to detect and measure changes in breast density. Eur J Radiol, 52: 276-82, 2004.
91. Highnam R, Pan X, Warren R, Jeffreys M, Davey Smith G, Brady M. Breast composition measurements using retrospective standard mammogram form (SMF). Phys Med Biol, 51: 2695-713, 2006.
92. Jeffreys M, Warren R, Highnam R, Smith, GD. Initial experiences of using an automated volumetric measure of breast density: the standard mammogram form. Br J Radiol, 79: 378-82, 2006.
93. McCormack VA, Highnam R, Perry N, dos Santos Silva I. Comparison of a new and existing method of mammographic density measurement: intramethod reliability and associations with known risk factors. Cancer Epidemiol Biomarkers Prev, 16: 1148-54, 2007.
94. Kataoka M, Atkinson C, Warren R, Sala E, Day NE, Highnam R, Warsi I, Bingham SA. Mammographic density using two computer-based methods in an isoflavone trial. Maturitas, 59: 350-7, 2008.
95. Ding J, Warren R, Warsi I, Day N, Thompson D, Brady M, Tromans C, Highnam R, Easton D. Evaluating the effectiveness of using standard mammogram form to predict breast cancer risk: case-control study. Cancer Epidemiol Biomarkers Prev, 17: 1074-81, 2008.
96. Oestreicher N, Capra A, Bromberger J, Butler LM, Crandall CJ, Gold EB, Greendale GA, Modugno F, Sternfeld B, Habel LA. Physical activity and mammographic density in a cohort of midlife women. Med Sci Sports Exerc, 40: 451-6, 2008.
97. Peters TM, Ekelund U, Leitzmann M, Easton D, Warren R, Luben R, Bingham S, Khaw KT, Wareham NJ. Physical activity and mammographic breast density in the EPIC-Norfolk cohort study. Am J Epidemiol, 167: 579-85, 2008.
98. Reeves KW, Gierach GL, Modugno F. Recreational physical activity and mammographic breast density characteristics. Cancer Epidemiol Biomarkers Prev, 16: 934-42, 2007.
99. Siozon CC, Ma H, Hilsen M, Bernstein L, Ursin G. The association between recreational physical activity and mammographic density. Int J Cancer, 119: 1695-701, 2006.